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Background: Persea americana seeds are widely used in traditional Mexican medicine to treat rheumatism, asthma,
infectious processes as well as diarrhea and dysentery caused by intestinal parasites.
Methods: The chloroformic and ethanolic extracts of P. americana seeds were prepared by maceration and their
amoebicidal, giardicidal and trichomonicidal activity was evaluated. These extracts were also tested against
Mycobacterium tuberculosis H37Rv, four mono-resistant and two multidrug resistant strains of M. tuberculosis as well
as five non tuberculosis mycobacterium strains by MABA assay.
Results: The chloroformic and ethanolic extracts of P. americana seeds showed significant activity against E.
histolytica, G. lamblia and T. vaginalis (IC50 <0.634 μg/ml). The chloroformic extract inhibited the growth of M.
tuberculosis H37Rv, M. tuberculosis MDR SIN 4 isolate, three M. tuberculosis H37Rv mono-resistant reference strains
and four non tuberculosis mycobacteria (M. fortuitum, M. avium, M. smegmatis and M. absessus) showing MIC values
≤50 μg/ml. Contrariwise, the ethanolic extract affected only the growth of two mono-resistant strains of M.
tuberculosis H37Rv and M. smegmatis (MIC ≤50 μg/ml).
Conclusions: The CHCl3 and EtOH seed extracts from P. americana showed amoebicidal and giardicidal activity.
Importantly, the CHCl3 extract inhibited the growth of a MDR M. tuberculosis isolate and three out of four mono-
resistant reference strains of M. tuberculosis H37Rv, showing a MIC = 50 μg/ml. This extract was also active against
the NTM strains, M. fortuitum, M. avium, M. smegmatis and M. abscessus, with MIC values <50 μg/ml.
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Persea americana Mill. (Lauraceae) is an edible fruit com-
monly known as aguacate (avocado) that grows throughout
the tropics. The seeds (crude or toasted) are employed in
traditional Mexican medicine to treat skin rashes, diarrhea,
and dysentery caused by helminths and amoebas, for the
cure of infectious processes caused by fungi and bacteria, as
well as for the treatment of asthma, high blood pressure,
and rheumatism [1-5]. The seeds of P. americana used
alone or mixed with other species, such as Psidium
guajava, Mentha piperita or Ocimum basilicum, are mainly
employed for the treatment of diarrhea [4].* Correspondence: adelinajim08@prodigy.net.mx
1Unidad de Investigación Médica en Farmacología (UIM), Hospital de
Especialidades, CMNS XXI, Instituto Mexicano del Seguro Social (IMSS), Av.
Cuauhtémoc 330, Col. Doctores, 06720, México, DF, Mexico
Full list of author information is available at the end of the article
© 2013 Jiménez-Arellanes et al.; licensee BioM
Creative Commons Attribution License (http:/
distribution, and reproduction in any mediumThe presence of fatty acids (linoleic, oleic, palmitic,
stearic, linolenic, capric and myristic acids), polyphenols
(catechin, isocatechin, protocyanidin, flavonoids, tan-
nins and proanthocyanidin monomerics), saponins,
glucosides (D-perseit, D-α-manoheptit, D-monoheptulose,
persiteol), sterols (β-sitosterol, campesterol, stigmasterol,
cholesterol), the amino acid carnitine and two glucosides
of abscicic acid has been described for P. americana seeds
[4-8]. High concentrations of catechins, procyanidins and
hydroxycinnamic acid have recently been determined in
100% ethyl acetate (EtOAc), in 70% acetone and 70%
methanol (MeOH) extracts obtained from P. americana peel
and seeds, while the pulp extract was rich in hydroxybenzoic
acid, hydroxycinnamic acid and procyanidins [9].
Interestingly, the hypolipemic effect of the MeOH ex-
tract obtained from P. americana seeds has been demon-
strated in male rats with induced hypercholesterolemiaed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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erides and Low density lipoprotein (LDL); on the other
hand, increased the levels of High density lipoprotein
(HDL). The same effect was described for the aqueous
extract, which also reduced blood pressure both in normal
rats and those with high blood pressure; in addition, it
exerted a hypoglycemic effect on rats and rabbits with
diabetes [12-15]. The aqueous extract showed a
median Lethal dose (LD50) = 10 g/kg in rats when it
was administered orally. Importantly, it did not alter
the hematological parameters nor the levels of Alanine
aminotransferase (ALT), Aspartate aminotransferase (AST),
albumin, and creatinine in male and female rats were
treated for 28 days [16].
The hexanic and MeOH seed extracts of P. americana
have been described to have a Minimum inhibitory
concentration (MIC) of <1.25 μg/ml against Candida ssp.,
Cryptococcus neoformans and Malassezia pachydermatis.
These extracts were also active against Artemia salina,
with Lethal concentration (LC50) values of 2.37 and
24.13 mg/ml, respectively. They were also active
against Aedes aegypti larvae with LC50 values of 16.7
and 8.9 mg/ml, respectively [17]. On the other hand,
the MeOH extract from P. americana leaves inhibited
completely the growth of M. tuberculosis H37Ra
(MIC = 125 μg/ml) and H37Rv (MIC = 62.5 μg/ml);
furthermore, the hexane fraction inhibited the growth
of both mycobacteria with MIC = 31.2 μg/ml [18]. In
addition, the EtOH extract was active against both
Gram-positive and -negative bacteria (with the exception
of Staphylococcus epidermis and Escherichia coli) with
MIC = 500 μg/ml [19]. Regarding the bacterial activity of
P. americana (var Hass and Fuerte), the acetone seed
extract exhibited moderate activity against Bacillus cereus,
Staphylococcus aureus and Listeria monocytogenes [9].
The trypanomicidal activity of the MeOH extract
from P. americana seeds has been also tested [20]. It
showed moderate activity when was evaluated at the
concentration range of 250–500 μg/ml. In the case of
the aqueous seed extract, it had a slight anti-Giardia
duodenalis (syn G. lamblia) activity, inducing 23% of
mortality at 4 mg/ml [21].
An important antioxidant activity (AOA) of the MeOH
extract of P. americana seeds and leaves has been
described by different methods [8,22-24]. Besides, AOA
has been reported in the 100% EtOAc, 70% acetone and
70% MeOH of the peel, pulp and seed extract [9].
Up to now, the activity of the chloroformic (CHCl3) and
ethanol (EtOH) extracts obtained from P. americana
seeds against anaerobic protozoan and M. tuberculosis
H37Rv strains with different level of drug resistance has
not yet been evaluated. Therefore, herein, the activity of
both extracts was tested against the anaerobic protozoa
Giardia lamblia, Entamoeba histolytica and Trichomonasvaginalis. In addition, their antimycobacterial activity was
evaluated against four mono-resistant reference strains of
M. tuberculosis H37Rv, two MDR M. tuberculosis clinical
isolates and five non-tuberculosis mycobacterium (NTM).Methods
Plant material
P. americana seeds were obtained from the town of Ario
de Rosales in the state of Michoacan, Mexico in August
2009. This material was then dried at room temperature
and under conditions of darkness; the material was then
ground. The plant was botanically identified by Abigail
Aguilar, M.Sc., and a voucher specimen was deposited at
the Herbarium of the Instituto Mexicano del Seguro
Social, Mexico (IMSSM) with code number 14256.Preparation of extracts
The dry and powdered plant material (1.364 kg) was
macerated three times with CHCl3 analytical reagent -
AR- (J.T. Baker) at room temperature for 7 days. The
extract was filtered and concentrated to dryness under
low pressure at 40°C. The plant material was later mac-
erated with EtOH AR grade (J.T. Baker) three times for
7 days and the solvent was eliminated under reduced
pressure until the solvent-free extract was obtained.Antiprotozoal activity evaluation
For this assay, the E. histolytica strain HM1-IMSS and the
T. vaginalis GT9 strain were cultured in a TYI-S-33 modi-
fied medium supplemented with 10% calf serum; G.
lamblia strain IMSS:0989:1 was maintained in a TYI-S-33
medium supplemented with 10% calf serum and bovine
bile. In vitro susceptibility assays were performed
according to the method previously described [25,26].
Briefly, 5 × 104 trophozoites of G. lamblia were incubated
for 48 h at 37°C with increasing concentrations of the
EtOH and CHCl3 extracts of P. americana seeds
using Dimethyl sulfoxide (DMSO) as a suitable solvent.
After incubation, G. lamblia trophozoites were washed
and subcultured for an additional 48 h in a fresh
medium alone. For E. histolytica and T. vaginalis, 6 ×
103 trophozoites were incubated for 72 h at 37°C
with increasing concentrations of the samples tested.
Metronidazole was included as a positive control;
parasites without treatment but with the highest DMSO
concentration used for sample dilutions were included as a
negative control. G. lamblia, T. vaginalis and E. histolytica
trophozoites were counted and the 50% Inhibitory
concentration (IC50) was calculated by Probit analysis.
The experiments were carried out in triplicate and repeated
at least twice.
Table 1 Antiprotozoal activity of the CHCl3 and EtOH
extracts from Persea americana seeds
Sample IC50 (μg/ml)
G. lamblia E. histolytica T. vaginalis
CHCl3 extract 0.634 0.417 0.524
EtOH extract 0.486 0.386 0.533
Metronidazole 0.210 0.06 0.037
IC50: medium Inhibitory concentration.
Table 2 Antimycobacterial effect of the CHCl3 and EtOH
extracts from Persea americana seeds
Mycobacterium
tuberculosis









SIN4 STR, INH, RIF, EMB, RFB,
ETH, and OFX
50 >100
MMDO INH, EMB 100 >100
Mono-resistant
RIF-R RIF >100 >100
INH-R INH 50 >100
STR-R STR 50 50
EMB-R EMB 50 50
NTB Mycobacterium
M. fortuitum 50 100
M. avium 25 100
M. chelonae 100 100
M. smegmatis 12.5 25
M. abscessus 25 100
SIN 4 MDR clinical isolate of M. tuberculosis resistant to STR: Streptomycin, INH:
Isoniazid, RIF: Rifampicin, EMB: Ethambutol, RFB: Rifabutin, ETH: Ethionamide
and OFX: Ofloxacin. MMDO MDR clinical isolates of M. tuberculosis resistant to
INH and EMB; the resistance pattern was determined by Microdilution alamar
blue assay (MABA). NTB: non-tuberculosis mycobacteria; MIC: Minimum
inhibitory concentration. Data are means of three determinations.
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For this assay, 12 Mycobacterium strains were employed:
M. tuberculosis H37Rv (ATCC 27294, a strain sensitive
to streptomycin (STR), isoniazid (INH), rifampicin (RIF),
etambutol (EMB), or pyrazinamide; M. tuberculosis SIN
4 (a MDR clinical isolate with resistance to first-line
drugs); M. tuberculosis MMDO (an MDR clinical isolate
with resistance to INH and EMB); four mono-resistant
strains of M. tuberculosis H37Rv (INH-R, ATCC 35822;
STR-R, ATCC 35820; RIF-R, ATCC 35838, and EMB-R,
ATCC 35837) and four NTM clinical isolates (M.
fortuitum, M. chelonae, M. abscessus and M. avium) and
M. smegmatis (ATCC 35798). The Mycobacterium strains
were grown and maintained in Middlebrook 7H9
broth supplemented with 10% OADC enrichment
(Becton Dickenson, USA) at 37°C until a logarithmic
growth phase was achieved. At the moment of evaluation,
M. tuberculosis strains and NTM were diluted 1:20 and
1:50, respectively in the 7H9 medium.
The antimycobacterial activity was carried out by means
of the Microplate alamar blue assay (MABA) previously
described [26,27]. EtOH and CHCl3 extracts (10 mg) were
solubilized in 500 μL of DMSO and from these stock
solutions, several dilutions were prepared to achieve
concentrations between 200 and 3.13 μg/ml. The max-
imum DMSO concentration used in the MABA assay
does not affect mycobacterial growth, as it was previously
reported [28]. Extracts that presented MIC <100 μg/ml
were considered to have good antimycobacterial activity.
Rifampicin and isoniazid at 0.06 μg/mL were included as a
positive control for the H37Rv strain, for the MDR clinical
isolates and for NTM; the same drugs were used but at
concentrations of 100 and 3.1 μg/ml, respectively.
Results and discussion
By means of the maceration process, 88.7 g of the CHCl3
extract and 77.2 g of the EtOH extract from P. americana
seeds were obtained with an average yield of 6% with re-
spect to the plant material’s dry weight. A preliminary
phytochemical analysis by Thin layer chromatography
(TLC) of the CHCl3 extract led to the detection of the
presence of β-sitosterol, phytol and palmitic acid. On the
other hand, catechin and epicatechin were detected in the
EtOH extract by TLC. All compounds were identified by
comparison of the Retention factor (Rf) with their com-
mercial reference. A previous study by Rodríguez-Carpena
et al. [9] reported a high concentration of catechin and
epicatechin in 100% EtOAc, 70% acetone and 70% MeOH
extracts obtained from P. americana seeds and peel.
The EtOH and CHCl3 extracts displayed significant
antiprotozoal activity. For G. lamblia, E. histolytica
and T. vaginalis, the CHCl3 extract showed values of
IC50 = 0.634, 0.417 and 0.524 μg/ml, respectively. On
the other hand, the EtOH extract exhibited IC50values of 0.486, 0.386 and 0.533 μg/ml against G. lamblia,
E. histolytica and T. vaginalis, respectively (Table 1).
Although the giardicidal activity of the aqueous seed
extract has been previously evaluated [21], the authors
used the 3-(4,5-dimetiltiazol-2-ilo)-2,5-difeniltetrazol
(MTT) colorimetric method; therefore our data can not
be compared.
It is interesting to note that, the reference drug,
metronidazole (IC50 = 0.210 μg/ml) showed only three
and two times higher anti-Giardia activity than the CHCl3
and EtOH extracts. However, in the case of E. histolytica,
the CHCl3 and EtOH extracts were seven and six times
less potent than metronidazole (IC50 = 0.060 μg/ml). For
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being 16 (CHCl3) and 17 (EtOH) times less potent than
metronidazole (CI50 = 0.037 μg/ml).
In traditional Mexican medicine, P. americana seeds
are used to treat diarrhea [1-4]. It is shown here that P.
americana EtOH and CHCl3 seed extracts are indeed
responsible for the activity against two anaerobic para-
sites that cause diarrhea: G. lamblia, and E. histolytica.
The in vitro and in vivo giardicidal activity of epicatechin
isolated from plants such as Rubus coriifolius and
Heliantemum glomeratus has been reported [29,30]. In
this regard, epicatechin was detected in P. americana
EtOH seed extract by TLC analysis; hence, this
compound may be responsible for the giardicidal activity
observed in this study. Further studies are required to
define the active compound(s) responsible for the
antiprotozoal activity of the CHCl3 extract.
It is worth considering the fact that the EtOH and
CHCl3 extracts constitute potential sources of compounds
that can be employed as prototype molecules for the devel-
opment of novel antiprotozoal agents as an alternative
treatment of clinical isolates with metronidazole resistance.
The results of the antimycobacterial activity of the
EtOH and CHCl3 extracts determined by MABA assay are
presented in Table 2. It is important to note that the
CHCl3 extract inhibited the growth of M. tuberculosis
H37Rv, MDR M. tuberculosis SIN 4 and three out of four
mono-resistant reference strains of M. tuberculosis H37Rv
(INH-R, STR-R, and EMB-R), showing a MIC = 50 μg/ml.
This extract was also active against the NTM: M.
fortuitum, M. avium, M. smegmatis and M. abscessus
with MIC values < 50 μg/ml. However, the EtOH extract
affected only the growth of M. smegmatis (MIC= 25 μg/ml)
and the mono-resistant strains of M. tuberculosis H37Rv
STR-R and EMB-R (MIC = 50 μg/ml).
To date, the hexanic and MeOH extracts obtained
from the stems and leaves of P. americana have been
reported to inhibit the growth of M. tuberculosis H37Rv
and M. tuberculosis H37Ra strains [18,31]. The reported
antimycobacterial activity of the MeOH extracts was
attributed to the presence of lignans [31] and the
MIC was slightly lower than the CHCl3 extract tested
in this study.
Since the presence of MDR and extensively drug-
resistant (XDR) M. tuberculosis cases is increasing rapidly
and current chemotherapy is prolonged, poorly effective,
expensive and is accompanied by severe side effects [26]; it
is necessary to have recourse to an alternative treatment
against these strains or that can even aid in and/or shorten
the currently available that could have a different mechan-
ism of action. Therefore, the high activity exhibited by the
P. americana CHCl3 seed extract against mono-resistant
strains of M. tuberculosis H37Rv, MDR clinical isolates and
NTM that is described in this study, it is of great interest.From the clinical point of view, NTM are becoming
relevant, because of the so-called mycobacteriosis and
are currently recognized as important pathogens associated
with both immune-deficient and immune-competent
patients. The mycobacteria tested in this study are repre-
sentative of the most common NTM isolated from pul-
monary cases (M. abscessus and M. avium) or associated
with soft tissue infections (M. fortuitum and M. chelonae)
[32]. Although M. smegmatis is a poor pathogenic
bacterium, it was included in the NTM group because
it is widely employed in the determination of the
antimycobacterial activity of new compounds [32,33]. In
the case of NTM, the majority is naturally resistant to some
of the first-line anti-TB drugs such as INH and RIF; thus,
effective drugs against NTM are scarce than those for TB,
emphasizing the urgency of finding novel active com-
pounds that could be used in the treatment of the NTM
group. Based on our results, P. americana seeds may be a
source for potential moieties (molecules) against NTM. We
are currently conducting the isolation and identification of
the active compounds responsible for the antimycobacterial
activity observed with the CHCl3 extract.
Conclusions
Herein, to the best of our knowledge, the activity of the
CHCl3 and EtOH seed extracts from P. americana
against two intestinal parasites that cause diarrhea: E.
histolytica, and G. lamblia has been demonstrated. In
addition, based on our results, CHCl3 seed extract may
be a source for potential moieties (molecules) against M.
tuberculosis drug-resistant species as well as NTM.
Further studies are required for the identification of
the active compounds responsible for the antiprotozoal
and antimycobacterial activity observed with the EtOH
and CHCl3 seed extracts from P. americana.
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